Tibulizumab - CAS 1849636-24-3

Tibulizumab (LY 3090106), a tetravalent bispecific monoclonal antibody, selectively binds to B-cell activating factor (BAFF) and IL-17A with dissociation constants (Kd) of 60 pM and 14 pM, respectively. This specificity renders it a valuable tool for autoimmune disease research.

Interleukin, TNF

Apoptosis, Immunology/Inflammation

1849609

-20°C

Ice Packs

Inhibitory Antibodies